Here’s whether Eli Lilly & Co. (LLY) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 62 — healthy momentum range; strong 1-year return of +26.1%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.40% over 10 days); 3-month momentum negative (-10.7%). Currently 18.2% off its 52-week high. Score: +1/7.
LLY is holding above its long-term 200-day MA ($905.36) but has slipped below the 50-day MA ($973.35), pointing to short-term weakness in an otherwise intact trend. An RSI of 61.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +26.1% compares to +35.1% for SPY (trailed the market by 8.9%).
$10,000 invested 1 year ago→ $12,614 today
vs. S&P 500 (SPY) — same period trailed market by 8.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($905.36)
✗Above 50-day MA ($973.35)
✓RSI(14) neutral zone (30–70) — currently 61.8
✓Positive return (+26.1%)
!Within 10% of period high (−18.3%)
Period Range $927.03
$623.78$1,133.95
RSI (14) 61.8
0 · OversoldOverbought · 100
Key Metrics
Price$927.03
Period Return+26.1%
Period High$1,133.95
Period Low$623.78
Drawdown−18.3%
MA-50$973.35
MA-200$905.36
RSI (14)61.8
Avg Volume (30d)2.8M
vs. SPYtrailed by 8.9%
Return Rank#519 of 996
Trend Signals
Price is above the 200-day moving average ($905.36)
Price is below the 50-day moving average ($973.35)